SECOND AMENDMENT AND AGREEMENTCollaborative Development and Marketing Agreement • December 23rd, 2005 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This SECOND AMENDMENT AND AGREEMENT (this “Agreement”) is entered into as of December 16, 2005 (the “Effective Date”), by and between PALATIN TECHNOLOGIES, INC., a Delaware corporation having an address of Cedar Brook Corporate Center, 4C Cedar Brook Drive, Cranbury, New Jersey 08512 (“Palatin”) and KING PHARMACEUTICALS, INC., a Tennessee corporation having an address of 501 Fifth Avenue, Bristol, Tennessee 37620 (“King”). Each of King and Palatin is sometimes referred to individually herein as a “Party” and collectively as the “Parties”. Any capitalized terms undefined herein shall have the meaning ascribed to them in the CDM Agreement.
